MCE products for research use only. We do not sell to patients.

Chlorpromazine hydrochloride

MCE China：Chlorpromazine hydrochloride

Brand：MedChemExpress (MCE)

Cat. No.HY-B0407A

CAS：69-09-0

Purity：99.87%

Storage：4°C, sealed storage, away from moisture and light *The compound is unstable in solutions, freshly prepared is recommended.

Shipping：Room temperature in continental US; may vary elsewhere.

Description：Chlorpromazine hydrochloride is an orally active, blood-brain barrier-transparent antipsychotic agent that effectively antagonises D2 dopamine receptors and 5-HT2A, which is widely used in schizophrenia and other psychiatric disorders. Chlorpromazine hydrochloride exerts anti-cancer activity through a variety of pathways, including anti-proliferation, induction of autophagy and cycle arrest (G2-M phase), inhibition of cytochrome c oxidase (CcO), inhibition of tumour growth and metastasis, and inhibition of tumour immune escape. Chlorpromazine hydrochloride also blocks hNav1.7 channels (IC50=25.9 μM; concentration-dependent) and HERG potassium channels (IC50=21.6 μM), which has potential for analgesic and cardiac arrhythmic studies. Chlorpromazine hydrochloride also can inhibit clathrin-mediated endocytosis.

In Vitro：Chlorpromazine hydrochloride (0, 10, 20, 40 μM; 0, 24, 48 h) inhibits growth of U-87MG glioma cells in a dose- and time- dependent manner[2]. Chlorpromazine hydrochloride (20 μM; 0, 12, 24, 48 h) decreases the levels of cyclin A and cyclin B1 in U-87MG glioma cells, 12 h later[2]. Chlorpromazine hydrochloride (20 μM) causes inhibition of cell cycle progression[2]. Chlorpromazine hydrochloride (10 μM; 1 h) significantly suppresses the sEV internalization and dramatically reduces MDSCs in sEV-treated bone marrow cells (MDSCs can significantly suppress the immune cell response, causing immunosuppression in cancer cells)[3]. Chlorpromazine hydrochloride (3, 10, 20, 40, 60 μM) blocks the hNav1.7 current in a concentration-dependent manner[4]. Chlorpromazine hydrochloride blocks HERG potassium channels with an IC50 value of 21.6 μM and a Hill coefficient of 1.11[5].

In Vivo：Chlorpromazine (20 mg/kg; i.p.; single daily for 7 days) hydrochloride inhibits xenograft tumor growth in nude mouse[2].

IC50 & Target：D2 dopamine receptors; 5-HT2A[1][6]. In Vitro Chlorpromazine hydrochloride (0, 10, 20, 40 μM; 0, 24, 48 h) inhibits growth of U-87MG glioma cells in a dose- and time- dependent manner[2]. Chlorpromazine hydrochloride (20 μM; 0, 12, 24, 48 h) decreases the levels of cyclin A and cyclin B1 in U-87MG glioma cells, 12 h later[2]. Chlorpromazine hydrochloride (20 μM) causes inhibition of cell cycle progression[2]. Chlorpromazine hydrochloride (10 μM; 1 h) significantly suppresses the sEV internalization and dramatically reduces MDSCs in sEV-treated bone marrow cells (MDSCs can significantly suppress the immune cell response, causing immunosuppression in cancer cells)[3]. Chlorpromazine hydrochloride (3, 10, 20, 40, 60 μM) blocks the hNav1.7 current in a concentration-dependent manner[4]. Chlorpromazine hydrochloride blocks HERG potassium channels with an IC50 value of 21.6 μM and a Hill coefficient of 1.11[5]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Chlorpromazine hydrochloride Related Antibodies Cell Proliferation Assay[2] Cell Line: U-87MG glioma cells

Hot selling product：Azomycin  | Ambroxol  | Proguanil  | ZQ-16  | S-Methylisothiourea (sulfate)  | Methyl palmitate  | Bellidifolin  | Phospho-AKT (Thr308) Antibody  | Ethylenediaminetetraacetic acid (disodium dihydrate)  | Clebopride (malate)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

References：

[1]. Kamgar-Dayhoff P, et al. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment. Oncotarget. 2021 Jul 6;12(14):1406-1426.  [Content Brief]

[2]. Shin SY, et al. The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis. 2013 Sep;34(9):2080-9.  [Content Brief]

[3]. Yang Z, et al. Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production. Cell Metab. 2022 Nov 2:S1550-4131(22)00461-2.  [Content Brief]

[4]. Lee SJ, et al. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Nav1.7. Neurosci Lett. 2017 Feb 3;639:1-7.  [Content Brief]

[5]. Thomas D, et al. The antipsychotic drug chlorpromazine inhibits HERG potassium channels. Br J Pharmacol. 2003 Jun;139(3):567-74.  [Content Brief]

[6]. Suzuki H, et al. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof. J Psychopharmacol. 2013 Apr;27(4):396-400.  [Content Brief]